Serum samples were analyzed for glucose, blood urea nitrogen (BUN), creatinine, cholesterol, aspartate aminotransferase (AST
Sci ., 2006 , 47 (9), 3951
With unapproved or grey-market peptides, the issues are obvious: no established safe dose for many compounds limited long-term human safety data purity and contamination risk uncertain storage and handling products that may not contain what the label says injection risk if people use injectable products anti-doping risk for athletes Even if a compound turns out to have real medical value in future, that does not mean today's online version is safe, legal, clean or appropriate for an athlete
Therapeutic approaches Limiting TMA precursors in individuals with elevated TMAO would be prudent
Some people experience more severe reactions, including gallbladder problems, pancreatitis, or gastrointestinal issues